GRRMF
Gerresheimer AG
OTC Markets OTCPKUSDEQUITY
DELAYED
Strong sell
-57/100
Last price
29.05
■ 0.00 (0.00%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
29.05
Day high
32.20
Day low
32.20
Volume
200
Market cap
—
P/E (TTM)
—
52W range
19.17 – 51.41
Trailing performance
Returnvs SPY
1W
0.00%
-1.9%
1M
-9.78%
-11.3%
3M
-12.89%
-16.3%
6M
+40.68%
+25.7%
YTD
-43.49%
-57.5%
1Y
-43.49%
-59.2%
3Y
-55.42%
-137.3%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Free account
3 more panels on GRRMF open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Fundamentals
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $2.32B | $1.99B | $1.99B | $1.82B | +16.6% |
| Operating revenue | $2.32B | $1.99B | $1.99B | $1.82B | +16.6% |
| Cost of revenue | $1.90B | $1.42B | $1.39B | $1.27B | +33.2% |
| Gross profit | $425.25M | $568.25M | $597.31M | $546.81M | -25.2% |
| Research & development | $80.98M | $23.75M | $16.13M | $21.62M | +240.9% |
| Selling, general & admin | $381.14M | $341.74M | $326.02M | $304.64M | +11.5% |
| Total operating expense | $496.04M | $376.18M | $367.85M | $353.10M | +31.9% |
| Operating income | -$70.79M | $192.07M | $229.47M | $193.71M | -136.9% |
| Net interest income | -$120.81M | -$50.66M | -$45.96M | -$28.50M | -138.5% |
| Pre-tax income | -$330.13M | $110.37M | $167.43M | $140.81M | -399.1% |
| Tax provision | -$11.41M | $26.03M | $47.34M | $38.62M | -143.8% |
| Net income | -$320.32M | $82.28M | $116.13M | $96.12M | -489.3% |
| Net income to common | -$320.32M | $82.28M | $116.13M | $96.12M | -489.3% |
| Basic EPS | -9.27 | 2.38 | 3.48 | 3.06 | -489.5% |
| Diluted EPS | -9.27 | 2.38 | 3.48 | 3.06 | -489.5% |
| EBIT | -$232.36M | $171.00M | $217.86M | $168.77M | -235.9% |
| EBITDA | $289.86M | $374.56M | $403.89M | $340.32M | -22.6% |
| Basic shares | 34.54M | 34.54M | 33.34M | 31.40M | 0.0% |
| Diluted shares | 34.54M | 34.54M | 33.34M | 31.40M | 0.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $176.21M | $186.38M | $122.34M | $112.79M | -5.5% |
| Cash & short-term investments | $190.93M | $213.06M | $143.53M | $124.83M | -10.4% |
| Accounts receivable | $331.52M | $271.94M | $268.01M | $269.83M | +21.9% |
| Inventory | $446.51M | $356.08M | $327.42M | $304.38M | +25.4% |
| Total current assets | $1.10B | $960.04M | $837.91M | $810.14M | +14.9% |
| Property, plant & equipment | $1.86B | $1.50B | $1.27B | $1.06B | +23.4% |
| Goodwill & intangibles | $1.47B | $1.24B | $1.26B | $1.32B | +19.3% |
| Total assets | $4.49B | $3.77B | $3.42B | $3.35B | +19.1% |
| Total current liabilities | $1.36B | $992.55M | $954.85M | $1.10B | +37.1% |
| Current debt | $549.51M | $345.91M | $365.73M | $519.63M | +58.9% |
| Long-term debt | $1.52B | $870.81M | $612.82M | $638.58M | +74.4% |
| Total debt | $2.17B | $1.28B | $1.05B | $1.22B | +69.5% |
| Total liabilities | $3.39B | $2.27B | $1.95B | $2.08B | +49.3% |
| Retained earnings | $907.05M | $712.95M | $675.35M | $614.48M | +27.2% |
| Shareholder equity | $1.08B | $1.48B | $1.44B | $1.24B | -26.8% |
| Working capital | -$258.01M | -$32.51M | -$116.94M | -$291.29M | -693.6% |
| Net tangible assets | -$393.39M | $241.61M | $176.88M | -$74.48M | -262.8% |
| Shares issued | 34.54M | 34.54M | 34.54M | 31.40M | 0.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$318.72M | $84.34M | $120.08M | $102.19M | -477.9% |
| Depreciation & amortisation | $522.23M | $203.56M | $186.03M | $171.56M | +156.5% |
| Change in working capital | $22.27M | $24.74M | $31.78M | -$47.52M | -9.9% |
| Operating cash flow | $209.53M | $238.95M | $294.34M | $221.94M | -12.3% |
| Capital expenditure | -$308.32M | -$369.51M | -$328.04M | -$241.50M | +16.6% |
| Investing cash flow | -$661.77M | -$344.20M | -$307.43M | -$256.18M | -92.3% |
| Financing cash flow | $452.97M | $168.27M | $40.35M | $44.24M | +169.2% |
| Free cash flow | -$98.80M | -$130.56M | -$33.70M | -$19.56M | +24.3% |
| End cash position | $173.09M | $183.94M | $122.26M | $98.13M | -5.9% |
| Line item | 2025-11-30 | 2025-05-31 | 2025-02-28 | YoY |
|---|---|---|---|---|
| Total revenue | $639.49M | $600.65M | $520.05M | +6.5% |
| Operating revenue | $639.49M | $600.65M | $520.05M | +6.5% |
| Cost of revenue | $637.72M | $442.82M | $393.30M | +44.0% |
| Gross profit | $1.78M | $157.83M | $126.75M | -98.9% |
| Research & development | $66.14M | $3.16M | $6.12M | +1,994.4% |
| Selling, general & admin | $71.69M | $105.31M | $103.17M | -31.9% |
| Total operating expense | $145.74M | $107.16M | $111.63M | +36.0% |
| Operating income | -$143.96M | $50.67M | $15.12M | -384.1% |
| Net interest income | -$36.09M | -$21.89M | -$40.44M | -64.9% |
| Pre-tax income | -$318.58M | $28.78M | -$25.32M | -1,207.1% |
| Tax provision | -$11.99M | $11.16M | -$7.83M | -207.5% |
| Net income | -$306.63M | $17.02M | -$18.01M | -1,901.2% |
| Net income to common | -$306.63M | $17.02M | -$18.01M | -1,901.2% |
| Basic EPS | — | 0.49 | -0.52 | — |
| Diluted EPS | — | 0.49 | -0.52 | — |
| EBIT | -$310.28M | $52.35M | $17.21M | -692.7% |
| EBITDA | $11.01M | $119.41M | $84.40M | -90.8% |
| Basic shares | — | 34.54M | 34.54M | — |
| Diluted shares | — | 34.54M | 34.54M | — |
| Line item | 2025-11-30 | 2025-05-31 | 2025-02-28 | YoY |
|---|---|---|---|---|
| Cash & equivalents | $176.21M | $177.45M | $150.79M | -0.7% |
| Cash & short-term investments | $190.93M | $203.46M | $183.85M | -6.2% |
| Accounts receivable | $331.52M | $290.78M | $322.22M | +14.0% |
| Inventory | $446.51M | $504.74M | $516.65M | -11.5% |
| Total current assets | $1.10B | $1.14B | $1.16B | -3.1% |
| Property, plant & equipment | $1.86B | $1.81B | $1.83B | +2.6% |
| Goodwill & intangibles | $1.47B | $1.74B | $1.78B | -15.3% |
| Total assets | $4.49B | $4.76B | $4.84B | -5.5% |
| Total current liabilities | $1.36B | $1.13B | $1.91B | +20.5% |
| Current debt | $549.51M | — | — | — |
| Long-term debt | $1.52B | — | — | — |
| Total debt | $2.17B | $2.21B | $2.16B | -1.5% |
| Total liabilities | $3.39B | $3.29B | $3.30B | +2.9% |
| Retained earnings | $907.05M | $748.33M | $728.42M | +21.2% |
| Shareholder equity | $1.08B | $1.44B | $1.51B | -24.9% |
| Working capital | -$258.01M | $8.04M | -$748.36M | -3,309.5% |
| Net tangible assets | -$393.39M | -$301.16M | -$269.97M | -30.6% |
| Shares issued | 34.54M | 34.54M | 34.54M | 0.0% |
| Line item | 2025-11-30 | 2025-05-31 | 2025-02-28 | YoY |
|---|---|---|---|---|
| Net income | -$306.59M | $17.62M | -$17.49M | -1,839.9% |
| Depreciation & amortisation | $321.29M | $67.05M | $67.19M | +379.2% |
| Change in working capital | $79.44M | -$15.28M | -$62.51M | +619.9% |
| Operating cash flow | $89.73M | $62.03M | -$27.78M | +44.7% |
| Capital expenditure | -$57.91M | — | -$480.49M | — |
| Investing cash flow | -$67.41M | -$54.44M | -$474.88M | -23.8% |
| Financing cash flow | $14.84M | $15.78M | $454.30M | -5.9% |
| Free cash flow | $31.82M | $359.92M | -$508.27M | -91.2% |
| End cash position | $173.09M | $149.60M | $138.13M | +15.7% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
29.05
+0.00% from price
SMA 20
30.31
-4.16% from price
SMA 50
31.00
-6.28% from price
SMA 100
31.48
-7.72% from price
SMA 200
33.38
-12.96% from price
EMA 12
29.47
-1.42% from price
EMA 26
30.21
-3.84% from price
EMA 50
30.69
-5.33% from price
RSI (14)
15.3
Oversold
MACD (12,26,9)
-0.74
Hist -0.10
ATR (14)
0.23
0.77% of price
Realised vol 30D
29.3%
Annualised
Bollinger upper
33.40
20, 2σ
Bollinger lower
27.22
20, 2σ
50 / 200 cross
Death
31.00 vs 33.38
Trend bias
Below 200
-12.96%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.52
Less volatile than market
Correlation to SPY
0.08
Largely independent
Realised vol 30D
29.3%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-62.7%
Peak to trough
Max drawdown 5Y
-85.3%
Peak to trough
ATR 14
0.23
0.77% of price
Beta (reported)
—
5Y monthly, from filing
Headlines
Gerresheimer AG (GRRMF) (Q2 2026) Earnings Call Highlights: Divestitures, Transformation ...
GuruFocus.com · 7d ago
What Gerresheimer (GXI) Said on Its Q2 Earnings Call
MarketBeat · 7d ago
Gerresheimer shares rise to over 3-week high as Q2 EBITDA jumps sequentially
Investing.com · 8d ago
Gerresheimer AG: Annual General Meeting Approves the Company's Proposed Resolutions by a Majority Vote
NewMediaWire · 36d ago
Pharmaceutical Packaging Market Report 2026-2036 Now Available — Forecasts Market Growth from $188.4B (2026) to $436.5B by 2036, Profiling Amcor, Gerresheimer, Schott, and 53 Other Key Players
GlobeNewswire · 37d ago
Gerresheimer (XTRA:GXI) Sells Assets For €1.5b, Is The Valuation Still Too Rich?
Simply Wall St. · 40d ago
Gerresheimer AG (GRRMF) (Q1 2026) Earnings Call Highlights: Strategic Divestitures and Cash ...
GuruFocus.com · 41d ago
Gerresheimer Q1 Earnings Call Highlights
MarketBeat · 41d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.